Skip to main content

Financial/Revenue Cycle Management

By Bernie Monegain | 10:44 am | December 20, 2016
The company will use the cash to meet the expanding demand for its suite of SaaS-based customer relationship management software.
By Mike Miliard | 12:36 pm | December 19, 2016
McKesson Enterprise Information Solutions has teamed with Infor for a go-to-market partnership aimed at helping healthcare organizations reduce costs by better managing their supply chains.
By John Andrews | 08:06 am | December 12, 2016
Robert DeMichiei outlines the University of Pittsburgh Medical Center’s journey toward activity-based costing as a means for survival in new world of CMS bundles and capitation. 
By Mike Miliard | 08:05 am | November 23, 2016
Healthcare IT News took the pulse of its Best Hospital IT Departments 2016 winners and found that progress on these fronts is fluctuating – from ‘dabbling’ today to leading-edge work toward next-generation care delivery.
By Mike Miliard | 02:42 pm | November 18, 2016
The provider tapped an EHR-based care management tool to cut readmissions by 30 percent, HIMSS said.
By Kaiser Health News | 11:07 am | November 18, 2016
Even though insurers and employers have tried to nudge consumers toward using retail health clinics for minor incidents, new research found a very slight decrease in ED visits, but only among privately insured patients.  
By Diana Manos | 08:27 am | November 18, 2016
Beth Israel Deaconess Medical Center CIO John Halamka advised providers to stay the course on MACRA, while iHealth partner Justin Barnes agreed that major changes are unlikely. But Robert Tennant of the MGMA cautioned that we won’t know until Trump takes over.
By Tom Sullivan | 08:18 am | November 11, 2016
Survey responses range from massive disruption to more competitive markets. Hospital leaders are hoping that prices go down but alternative payment models MACRA, MIPS and the Medicare Shared Savings Program remain. 
By Jack McCarthy | 10:50 am | November 07, 2016
Researchers said that testing for venous thromboembolisms can be both an unnecessary expense and in some cases harmful to patients. 
By Bernie Monegain | 10:26 am | November 03, 2016
CEO Jay Deady says that the new money will go toward product development of its revenue cycle technologies.